October 11, 2005. Fears of an avian flu pandemic have been kind to BioCryst Pharma, which has a treatment for flu that has shown some promise against this strain of the virus. The stock, which has traded as low as $3.68 during the past year, hit a high today over $15. On very active trading at midday, it was changing hands at $14.81, a rise of $1.83 or 14.1%. BioCryst is definitely the flavor of the moment: it was trading just above $10 a share as recently as three days ago. We look at this drug and at all the possible treatments for avian flu...
